Genenta Science
Biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.
Launch date
Employees
Market cap
$72.9m
Enterprise valuation
$52m (Public information from Sep 2024)
Share price
$3.85 GNTA
Company register number MI2045555
Milan Lombardy (HQ)
Authorizing premium user...